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Abstract
Retroviruses require integration of their RNA genomes for both stability and productive viral replication. In HIV infection of non-dividing,
resting CD4 T cells, where integration is greatly impeded, the reverse transcribed HIV DNA has limited biological activity and a short half-life. In
metabolically active and proliferating T cells, unintegrated DNA rapidly diminishes with cell division. HIV also infects the non-dividing but
metabolically active macrophage population. In an in vitro examination of HIV infection of macrophages, we find that unintegrated viral DNA not
only has an unusual stability, but also maintains biological activity. The unintegrated linear DNA, 1-LTR, and 2-LTR circles are stable for at least
30 days. Additionally, there is persistent viral gene transcription, which is selective and skewed towards viral early genes such as nef and tat with
highly diminished rev and vif. One viral early gene product Nef was measurably synthesized. We also find that independent of integration, the
HIV infection process in macrophages leads to generation of numerous chemokines.
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As with all retroviruses, the HIV RNA genome needs to be
reverse transcribed into a double-stranded DNA molecule that is
subsequently integrated into the host chromatin. This proviral
DNA serves as a template for viral transcription and progeny
production. Integration is believed to be an obligatory step for
viral replication (Donehower and Varmus, 1984; Engelman
et al., 1995; Schwartzberg et al., 1984;Wiskerchen andMuesing,
1995), and yet the natural process of HIV infection generates
excessive amounts of unintegrated viral DNA, which accumu-
lates in the lymphatic tissue, the brain, as well as the peripheral
T cells (Kim et al., 1989; Muesing et al., 1985; Pang et al., 1990;
Pauza et al., 1990; Robinson and Zinkus, 1990; Shaw et al.,⁎ Corresponding author. Department of Molecular and Microbiology, George
Mason University, 10900 University Boulevard, MS 4E3, Manassas, VA 20110,
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doi:10.1016/j.virol.2007.11.0071984; Stevenson et al., 1990b; Teo et al., 1997). The biological
implication for this excessive presence of unintegrated viral
DNA is still not fully understood. There have been numerous
experimental inquiries into possible significance of unintegrated
DNA. Early studies largely focused on using integration de-
fective viruses that carry low-level biological activity (Engelman
et al., 1995; Stevenson et al., 1990a,b;Wiskerchen andMuesing,
1995). It has been demonstrated that a subset of integrase mu-
tants, with mutations in the catalytic residues, are capable of
mediating transactivation of an indictor gene linked to the viral
LTR promoter, suggesting the synthesis of Tat (Engelman et al.,
1995;Wiskerchen andMuesing, 1995). Subsequently, transcrip-
tion from unintegrated viral DNA was shown to also occur
without altered integrase activity (Brussel and Sonigo, 2004;Wu
and Marsh, 2001, 2003). This pre-integration transcription was
suggested to be a normal early process in HIV-1 infection, which
is characterized by the transcription of all viral genes. However,
only early proteins such as Nef were detected (Wu and Marsh,
2003). The restriction to early protein syntheses does not appear
Fig. 1. Persistence of unintegrated HIV-1 DNA in macrophages. Total cellular
DNA harvested at indicated time points post-infection with Wt or D116N (equal
p24 level) was PCR amplified with primers specific for HIV-1, as described in
Materials and methods. For all PCR amplification, series dilutions were made to
ensure amplification is within the liner range (data not shown). All these PCR
conditions did not amplify products from uninfected cells (first lanes on the left,
Cell). Total cellular DNA was amplified with primers for viral late reverse
transcription products (A). The DNA was also amplified for detection of inte-
gration by Alu-PCR (B) and unintegrated circular viral DNA forms, both 1-LTR
circle and 2-LTR circle, as indicated (C). For relative comparison, cellularβ-actin
pseudo-gene was amplified to ensure equal amount of cellular DNA used for
amplification (D). To demonstrate that the unintegrated viral DNA was newly
synthesized, we treated cells with AZT (50 μM) for 12 h and then infected with
D116N in the continuous presence of AZT for 5 days. Total cellular DNAwas
purified and amplified by real-time PCR for viral DNA (E). AZT-untreated,
D116N-infected cells were used for comparison.
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translation of unspliced transcripts (Wu and Marsh, 2003).
Another HIV-1 accessory protein, Vpr, has also been suggested
to be involved in pre-integration transcription. Deletion of Vpr
decreases transcription from unintegrated HIV DNA 10- to 20-
fold (Poon and Chen, 2003).
Most of these studies have been limited to T cells or proli-
ferating cell lines, where unintegrated HIV DNA is short-lived
(Wu and Marsh, 2003; Zhou et al., 2005), and pre-integration
transcription was largely viewed as a transient process. Natural
HIV targets also include CD4 macrophages and brain microglia.
These non-cycling cells are derived from bone marrow and
perform similar functions (Hickey et al., 1992; Kennedy and
Abkowitz, 1997; Lawson et al., 1992; Santambrogio et al.,
2001). In the brain, HIV infection is largely limited to perivas-
cular macrophages and parenchymal microglia (Koenig et al.,
1986; Lackner et al., 1991; Shaw et al., 1985). HIV infection of
macrophages is commonly viewed as non-cytopathic, in con-
trast to the high turnover of T cells following HIV infection (Ho
et al., 1995). However, infected macrophages serve as an im-
portant viral reservoir (Crowe et al., 2003) and initiate aberrant
immunological responses that may directly contribute to patho-
genesis. Secreted products from infected macrophages, such as
chemokines, may recruit not only the desirable antiviral cyto-
toxic T lymphocytes but also susceptible uninfected CD4 Tcells
(Agostini et al., 2000; Fantuzzi et al., 2001; Foley et al., 2005;
Schmidtmayerova et al., 1996; Swingler et al., 1999; Tedla
et al., 1996). Furthermore, secreted inflammatory factors, and
possibly viral products, are believed to be responsible for neu-
ronal death and the impairment of cognitive function in HIV-
infected individuals (Ciborowski and Gendelman, 2006; Kaul
and Lipton, 2006).
Macrophages also harbor large quantities of unintegrated
viral DNA. For example, levels of unintegrated viral DNAwere
found to be more than 10 times higher than integrated DNA in
the brain (Pang et al., 1990). In T cells, unintegrated HIV-1
DNA has been shown to modulate resting T cell activity (Wu
and Marsh, 2001), and to down-regulate CD4 receptors (Gillim-
Ross et al., 2005b). Compared to T cells, much less is under-
stood concerning the stability and transcriptional activity of
unintegrated viral DNA in macrophages. In this report, we de-
monstrate that macrophages have the capacity to support sus-
tained viral transcription from unintegrated DNA. We also
demonstrate that similar to proviral DNA, the unintegrated
DNA has a capacity to induce chemokines such as CXCL9 and
CXCL10. These data suggest that macrophages can mediate
long-term, low-level viral and virus-mediated cellular activities
from unintegrated DNA, which may aid viral dissemination and
virus-mediated pathogenesis.
Results
Persistence of unintegrated viral DNA in macrophages
To investigate possible accumulation and transcription of
unintegrated HIV DNA in macrophages, we set up an in vitro
macrophage culture system and examined viral DNA synthesisfollowing infection. Macrophages were derived from peripheral
monocytes by culturing in macrophage colony stimulating
factor (M-CSF) (10 ng/ml) for 2 weeks. Following differentia-
tion, cells were infected with HIV-1AD8 (Wt) or its integration-
negative mutant, HIV-1AD8/D116N (D116N) (Englund et al.,
1995), using equal p24 viral input. HIV-1AD8/D116N was derived
from HIV-1AD8 by introducing a single point mutation, Asp-to-
Asn substitution, into the integrase catalytic domain, which
302 J. Kelly et al. / Virology 372 (2008) 300–312affects the invariant D-116 residue within the integrase D(35)E
motif (Engelman et al., 1995). This single point mutation has
been shown to completely abolish viral DNA integration with-
out affecting other known functions such as reverse transcrip-
tion and nuclear targeting (Engelman et al., 1995; Wiskerchen
and Muesing, 1995). We followed viral replication for appro-
ximately 30 days. No viral replication was observed in D116N-
infected cells, whereas robust viral replication was seen in the
wild-type-infected cells, with a peak of virus release at around
day 15 (data not shown). Our results confirm a previous de-
monstration of an essential role for integration in HIV-1 infec-
tion of macrophages (Englund et al., 1995), although a
conflicting report exists (Cara et al., 1995).
Although unable to integrate, viral DNA synthesized from
the T tropic D116N was found to be present transiently in Tcells
(Engelman et al., 1995; Wiskerchen and Muesing, 1995; Wu
and Marsh, 2001, 2003). However, in macrophages, we found
that the unintegrated DNA from HIV-1AD8/D116N persisted for at
least 30 days until the termination of the cell culture (Fig. 1A).
Alu-PCR amplification resulted in no detection of integration in
D116N infection at any time point, whereas in the wild-type-
infected cells, integrated viral DNA was readily detectable at
48 h and increased with time (Fig. 1B). This is consistent with
previous in vitro assays demonstrating that the D116N mutation
completely abolishes all enzymatic activities of the integrase,
such as 3′ processing, strand transfer and disintegration (En-
gelman and Craigie, 1992). Two of the unintegrated viral DNA
forms, both the 1-LTR and the 2-LTR circles, were found toFig. 2. Quantification of 1-LTR circles by competitive PCR. (A) Construction of the 1
methods. The competitor carrying a newPacI site was used to distinguish it from 1-LT
with serially diluted, known copies of the competitor DNA. The copy numbers of the
real-time PCR, using the same DNA standard for measuring linear DNA and 2-LTR ci
primers, products were digested with PacI. DNA amplified from 1-LTR circles showe
into two small fragments about 0.6 and 0.4 kb, respectively (b, c). When the molar rati
number.persist with viral infection (Fig. 1C). The D116N-infected cells
had higher levels of 2-LTR circles, similar to previous findings
of higher levels of 2-LTR circles in D116N-infected T cells
(Engelman et al., 1995; Wiskerchen and Muesing, 1995; Wu
and Marsh, 2003). However, the difference was not as sig-
nificant as in infected T cells, particularly at later stage of viral
infection (after 20 days). The non-integrated viral DNA de-
tected in D116N-infected macrophages is mostly newly syn-
thesized since the addition of the reverse transcriptase inhibitor,
AZT, diminished the viral DNA synthesis (Fig. 1E).
Among the non-integrated, circular viral DNA forms, the
1-LTR circles appeared to be far more abundant than 2-LTR
circles (Fig. 1C). However, it was likely that when 1-LTR and
2-LTR circles were amplified together, 1-LTR circles were pre-
ferentially amplified because of their smaller size. We further
quantified individual forms of unintegrated DNA by separate
methods. Full-length viral DNA and the 2-LTR circle were
measured by real-time PCR, whereas the 1-LTR circles cannot
be directly measured due to the lack of specific primers to dis-
tinguish it from the 2-LTR circle. Thus, 1-LTR circle was
measured by a competitive PCR approachwe developed (Fig. 2).
As shown in Table 1, in the wild-type-infected cells, the 1-LTR
and 2-LTR circles were roughly at the same level (5.5–14.3%
for 1-LTR circles; 11.8% for 2-LTR circles) and constituted
about 20% of the total viral DNA, whereas in D116N-infected
cells, the 1-LTR and the 2-LTR circles were about 10% and
37.4%, respectively. We assume that the rest of the viral DNA
was the linear DNA plus small amounts of irregular DNA-LTR circle competitor. Cloning of the competitor was described in Materials and
R circles. Total cellular DNA fromD116N (B) orWt (C)-infected cells was mixed
competitor DNAwere determined through three independent measurements by
rcle shown in Table 1. Following PCR amplification with LTR-nef2 and LTR-gag
d a size about 1 kb (a), whereas DNA amplified from the competitor was digested
o between “a” and “b” is one, 1-LTR circle and the competitor have an equal copy
Table 1
Quantification of HIV DNA in macrophages infected for 30 days
Total
DNAa
1-LTR
circle b
2-LTR
circle c
1-LTR
circle (%) d
2-LTR
circle (%) e
Wt 5557.3±1.2 310.0–792.8 656.0±1.4 5.5–14.3% 11.8%
D116N 2478.4±1.1 196.8–310.0 926.4±1.2 7.9–12.5% 37.4%
a Late products of HIV reverse transcription measured by real-time PCR
(copies in 20 ng total cellular DNA, three independent measurements).
b 1-LTR circles measured by competitive PCR as described in Fig. 3 (copies in
20 ng total cellular DNA). Shown are estimated ranges of 1-LTR-cricles.
c 2-LTR circles measured by real-time PCR (copies in 20 ng total cellular
DNA, three independent measurements).
d Percentage of 1-LTR circle in total HIV DNA.
e Percentage of 2-LTR circle in total HIV DNA.
303J. Kelly et al. / Virology 372 (2008) 300–312forms normally associated with retrovirus infection (Farnet and
Haseltine, 1991; Lee and Coffin, 1990; Shoemaker et al., 1980,
1981).
Persistence of transcriptional activity from unintegrated viral
DNA in macrophages
To determine possible transcriptional activity of unintegrated
viral DNA in macrophages, we amplified total cellular mRNA
by RT-PCR as previously described (Wu and Marsh, 2001,
2003) (Figs. 3A and B). Consistent with the persistence of
unintegrated DNA, we observed the persistence of viral tran-
scription in D116N-infected macrophages; the unintegrated
viral DNA remained transcriptionally active for a minimum of
30 days (Fig. 3C). Multiple viral transcripts, including all
classes of viral splicing isoforms, were detected. In comparison
with the wild type, the pattern of viral transcription from D116N
was different and selective. The unintegrated DNA predomi-
nately transcribed nef, tat, env, and gag-pol with diminished
rev and vif transcripts. In addition, the ratio between two of
the tat isoforms, tat1 and tat2, was reversed, with equal or
slightly higher tat 2 amplified, whereas in cells infected with the
wild-type virus, after 3 days tat 1 was strongly amplified (Fig.
3C, compare lanes 5–8 with lanes 13–16).
During early post-infection (4 to 12 h), transcription from the
wild-type virus shared a similar pattern as that from D116N
(Fig. 3C, compare lanes 1–2 with lanes 9–10). Presumably, this
early transcription in the wild-type infection may also be de-
rived from unintegrated DNA. Similar pre-integration transcrip-
tion has been reported in HIV infection of T cells (Wu and
Marsh, 2001, 2003). Indeed, viral integration was undetectable
before 12 h when these transcripts were present (Fig. 2B). After
12 h, viral transcription increased significantly in the wild-type
infection. Presumably, this enhanced transcriptional activity in
the wild-type infection was initiated from provirus following
integration.
The generation of viral transcripts from D116N infection is
the result of de novo viral DNA synthesis. Treatment of mac-
rophages with AZT during infection drastically inhibited viral
DNA synthesis (Fig. 3D), as well as the synthesis of the nef
transcript (Fig. 3E). Secondly, although infected macrophages
contain some plasmid DNA carried over by virion particles,
these contaminating DNA molecules do not appear to play asignificant role in mediating viral transcription. Treatment of
virion particles with Benzonase prior to infection reduced
carryover DNA by three log[10] (Fig. 3F), but no significant
reduction in viral transcription was observed (Fig. 3G). This is
in great contrast to the inhibitory effect of AZT (Fig. 3E),
demonstrating that active transcription in D116N infection
depends on newly synthesized viral DNA.
Viral protein syntheses from unintegrated DNA
We also examined the capacity of unintegrated viral DNA to
direct viral protein syntheses in macrophages. Infected cells
were harvested for western blot, which was probed with human
anti-HIV-1 antisera as described (Wu and Marsh, 2003). Viral
p24 was detected early (4 h post-infection) both in D116N and
wild-type HIV-infected cells (Fig. 4A). This protein diminished
with the D116N infection, suggesting that it was residual from
input virion particles in the D116N infection. The antisera also
detected a band with a similar size as the viral p24 precursor,
p55gag. The same band was detected from uninfected cells
(Fig. 4A, lane 2) and its level did not increase over the course
of D116N infection (Fig. 4A, lanes 3 to 8), suggesting it is a
cellular protein. Thus, we conclude that there was no mea-
surable viral structural protein synthesis in cells infected with
D116N. In contrast, in cells infected with the wild-type virus,
p55gag, along with other viral structural proteins, accumulated
with time (Fig. 4A, lanes 9 to 14). The blot was reprobed with a
sheep Nef antiserum (Pandori et al., 1996). We detected a
protein similar to the size of Nef in wild-type virus-infected
cells, and this Nef band peaked at day 2 in D116N infection
(Fig. 4B). Because the Nef antiserum also recognized a weak
band similar to the size of Nef in uninfected macrophages, we
performed additional experiments to determine whether the Nef
band detected in D116N infection was indeed Nef. We first
deleted the nef gene from D116N (Figs. 4G and H) and then
used the D116NΔnef to infect macrophages. Cell lysates were
harvested at days 2 and 3 post-infection and analyzed by
western blotting with a different Nef antiserum from rabbit
(Shugars et al., 1993). Consistently, we observed a similar Nef
band that was much stronger than the background band in
uninfected cells (Fig. 4I). Indeed, deletion of Nef reduced this
band to the uninfected, background level (Fig. 4I). These data
confirm that the protein detected by these two Nef antisera in
D116N infection was Nef. Nevertheless, the amount of Nef in
D116N-infected cells was much lower than that in the wild-
type-infected cells (Fig. 4B). Quantification of the Nef protein
generated by D116N revealed that it was approximately 6 to
10% of that generated by the wild type at day 2 (Figs. 4E and F).
The other two early viral products, Tat and Rev, are poorly
detectable by western blotting and remain undetected here, but
given the previous demonstration of functional expression of
Tat by D116N HIV (Wiskerchen and Muesing, 1995), as well as
the inability to detect Tat and Rev even in wild-type HIV in-
fection by western blotting, we cannot exclude expression of
these early genes with the D116N virus. The restricted syn-
theses of only viral early proteins by D116N were similar to
what we have observed in D116N infection of T cells (Wu and
304 J. Kelly et al. / Virology 372 (2008) 300–312Marsh, 2003). Previously, we have shown that the restriction on
structural protein syntheses was due to a lack of Rev function
(Wu and Marsh, 2003). Rev is essential for the transition from
early to late protein syntheses (Pollard and Malim, 1998). The
Rev transcript was at a low level over the course of D116N
infection of macrophages. Presumably, this minimal amount of
Rev was not adequate for its function to turn on viral structural
protein syntheses in the absence of integration.Chemokine induction by unintegrated viral DNA in macrophages
In a prior study with quiescent T cells, we have demonstrated
that transcription from unintegrated HIV DNA can alter the
outcome of Tcell activation andHIVreplication (Wu andMarsh,
2001). The biological response of macrophages to HIV infection
includes the generation of various chemokines and inflamma-
tory cytokines (Canque et al., 1996; Clouse et al., 1991; Fantuzzi
305J. Kelly et al. / Virology 372 (2008) 300–312et al., 2001; Gruber et al., 1995; Mengozzi et al., 1999; Schmid-
tmayerova et al., 1996). To evaluate possible contribution of
unintegrated HIV DNA to the biological response in macro-
phages, we assayed for various chemokine inductions following
HIV infection. Initially, we performed assays on the supernatant
of infected cells with a cytometric bead array for chemokines
and inflammatory cytokines. This assay included the chemo-
kines CXCL8 (IL-8), CCL5 (RANTES), CXCL9 (MIG), CCL2
(MCP-1), and CXCL10 (IP-10), and the inflammatory cytokines
TNF, IL-10, IL-1β, IL-6, IL-8, and IL-12p70. We infected
macrophages with equivalent levels of HIV-1AD8 and the in-
tegrase mutant HIV-1AD8/D116N, followed by chemokine and
cytokine measurement. Many of the previous studies cited
above examined macrophage infection for periods in excess of
1–2 weeks; however, we noted that with these long periods of
experimental incubation there was greater variability in cell
viability and large-cell formation, along with varied donor-
dependent chemokine expression (data not shown). When we
looked at earlier time points (2–4 days), we found reproducible
(from donor to donor) chemokine responses. CCL2 levels were
elevated in all macrophage preparations independent of HIV
exposure (data not shown), and this may be related to M-CSF,
which was used here to differentiate the monocytes to mac-
rophages, and has been shown to also induce CCL2 (Shyy et al.,
1993). Furthermore, CCL5 was induced in HIV-infected mac-
rophages in only one of four donors (data not shown). With the
exception of CXCL8 (IL-8, see below), none of the cytokines
from the cytometric bead arrays were notably induced by day 4
(data not shown). However, the chemokines CXCL10 and
CXCL9, as well as cytokine/chemokine CXCL8, were found to
be induced in macrophages from all donors within 4 days,
following infection with wild-type HIVor the integrase mutant
HIV (see Table 2). From p24 staining of wild-type HIV-infected
cells, we would estimate that the infection levels approximated
ten percent of cells (10.2±2.5%, mean±SE, n=5). Additionally,
the inclusion of AZT, which inhibits de novo viral DNA
synthesis, reduced the induction of CXCL9 and CXCL10 at day
four to levels comparable to uninfected populations (Table 2).
Relative to wild-type virus, the addition of AZTalso diminished
CXCL8, but for this chemokine, the induced levels in the
presence of AZTapproached the levels that were achieved by the
addition of D116N.
We reproduced the same experiment in monocyte-derived
macrophages from three additional donors, but this time per-
formed three independent infections of cells from each donorFig. 3. Persistence of transcription from unintegrated HIVDNA in infectedmacrophag
primers used for RT-PCR. (B) Total cellular RNA from infected cells (12 h post-infectio
products from RT-PCR using primers specific for gag-pol, vif, env, tat, rev, and nef. No
To confirm that the amplification of the gag-pol transcript did not result from DN
transcription (−RT). (C) Time course of viral transcription in D116N andWt infection
amplified as in panel B. To ensure that the comparisons were quantitative, we norma
QuantumRNA β-actin Internal Standards with a ratio of 1/9 for actin primer/competit
newly synthesized viral DNA, we treated cells with AZT (50 μM) for 12 h and then inf
infection and amplified for viral DNAby real-time PCR (D116N, 3721.7±409.7 copie
DNA carryover from virion particles, we also treated D116N virions with Benzona
Benzonase-treated or -untreated virions were purified and subjected to real-time PC
copies) (F). Benzonase-treated or untreated virions were also used for infection of m
subjected to RT-PCR amplification for the nef transcript (G).and measured CXCL10 by ELISA (Fig. 5). This procedure
permits multiple measurements of a chemokine induction from
the same donor, something we did not perform on the costly
bead array. Induction of CXCL10 secretion occurred with wild-
type virus, and this induction was again prevented by the
inhibition of reverse transcriptase. The addition of similar levels
of D116N also resulted in the induction of CXCL10, an effect
also diminished by AZT. The CXCL10 secretion seen with the
integrase mutant was reduced, relative to wild-type virus, and
this reduction is presumably due to the loss of secondary
infection by the mutant virus, and limited viral protein synthesis
(Fig. 5). The ability of AZT to diminish HIV induction of the
chemokines suggests that the effect is mediated by post-reverse
transcription activity but does not require completion of
integration. Our result is consistent with the findings of Foley
et al. (2005), who noted that HIV infection of macrophages
rapidly induced CXCL10 transcription. The authors reported
that this response of macrophages to HIV appeared to be
independent of the viral envelope engagement but did require a
post-reverse transcription process (Foley et al., 2005).
Discussion
In this article, we demonstrate that unintegrated HIV-1 DNA
can persist and remain active for transcription in infected mac-
rophages. Multiple unintegrated viral DNA forms, the linear
and the 1-LTR and 2-LTR circles, were found to persist for at
least 30 days. Transcription in the absence of integration is
selective and skewed towards certain viral early genes such as
nef and tat, with highly diminished rev and vif. While no
structural proteins were measurably synthesized, one viral early
protein, Nef, was detectable. These results were reproduced in
macrophages cultured from four different donors. The persis-
tence of unintegrated viral DNA in macrophages was in contrast
to its transient presence in proliferating T cells (Wu and Marsh,
2003), in which pre-integration transcription peaks at about 12 h
and diminishes within 3 days, and the unintegrated viral DNA
such as 2-LTR circles diminishes as a result of T cell division
(Butler et al., 2002; Pierson et al., 2002).
The nature of the transcribing, unintegrated HIV DNA has
not yet been determined. Previous studies have suggested that
the 2-LTR circles could be the template (Engelman et al., 1995;
Wiskerchen and Muesing, 1995). This was largely based on the
fact that higher than wild-type levels of 2-LTR circles were
found in T cells infected with integrase mutants (Engelmanes. (A) Schematic representation of RT-PCR amplification of viral transcripts and
n) was amplifiedwith RT-PCR as described inMaterials andmethods. Shown are
ne of these primer pairs amplified human sequences from uninfected cells (Cell).
A contamination, we also directly amplified RNA in the absence of reverse
. Total cellular RNA from infected cells was harvested at different time, and then
lized samples by the content of the co-amplified cellular β-actin transcript using
or. To confirm that the transcripts detected in D116N infection was derived from
ected themwith D116N. Total cellular DNA and RNAwere purified at day 1 post-
s; +AZT, 78.8±4.6 copies) (D) or the nef transcript by RT-PCR (E). To control for
se (100 U/ml) for 30 min at 37 °C or not treated. DNA from 300 ng (p24) of
R measurement of viral DNA (D116N, 2.7×109 copies; +Benzonase, 1.1×106
acrophages. RNA from infected cells (day 1 post-infection) was extracted and
Fig. 4. Viral protein synthesis from unintegrated DNA in infected macrophages. Lysates from infected cells were resolved and blotted with human anti-HIVantisera (A),
or a sheep Nef antiserum (B), or a monoclonal antibody against human actin as a loading control (D). To serve as a Nef control, we applied 0.5 ng of purified HIV-1 Nef
protein (lane 1) and uninfected macrophages (lane 2) to the gel. Protein bands were detected by incubation with corresponding secondary antibodies conjugated to
peroxidase and visualized by chemiluminescence. Panel C is a shorter exposure of panel B. Quantification of the Nef protein in panel B was performed as previously
described (Liu et al., 2001). Integration of chemiluminescence signal yielded the relative intensities of the Nef protein (arbitrary units): lane 1 (purified Nef), 2537 U;
lane 4 (D116N, day 2), 113 U; lane 5 (D116N, day 3), 120 U; lane 10 (Wt, day 2), 1835 U; lane 11 (Wt, day 3), signal saturated. The Nef protein standard and a repeat of
the Nef western blot from a separate infection with either Wt or D116N (Dn) are shown in panels E and F. A Nef-expression Jurkat cell line was used as a control. To
confirm the synthesis of the Nef protein from D116N, we constructed a D116N nefmutant by inserting a Nef-stop-linker sequence (G). The nef deletion was confirmed
by sequencing analysis and western blotting of infected Rev-CEM indicator cells (H). (H) Rev-CEM was infected with an equal p24 level (3 μg per million cells) of
D116N or D116NΔnef, and cell lysates were prepared at 48 h for western blotting for Nef, HIV-1 p24, or β-actin for loading control. Lane 1 is 0.5 ng of purified Nef
protein. (I) Macrophages were also infected with an equal p24 level of D116N or D116NΔnef. Cell lysates were prepared at days 2 and 3 post-infection. Blots were
probed, stripped, and reprobed similarly as in panel H with antibodies specific to Nef, p24, or β-actin.
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Table 2
Induction of chemokine secretion by HIV-1
Chemokine Wild-type
HIV (pg/ml)
Integrase-negative
HIVa (pg/ml)
Not infected
(pg/ml)
Wild-type HIV
plus AZT (pg/ml)
CXCL8 1275±561
(n=5)
717±334
(n=3)
248±57
(n=5)
773±333
(n=6)
CXCL9 297±84
(n=5)
60±18
(n=3)
21±10
(n=5)
11±4
(n=6)
CXCL10 2902±699
(n=6)
1172±892
(n=3)
323±69
(n=6)
135±55
(n=6)
Monocyte-derived macrophages from multiple donors (n=3–6) were infected
with either wild-type HIV-1AD8, or integrase mutant HIV-1AD8/D116N or not
infected, with or without AZT. After 4 days incubation, cell supernatants from
infected and non-infected populations were assayed by cytometric bead array.
The level of chemokine is listed as the mean value in pg/ml±SE. In assays that
individual donor samples were not measured in replicate, the variation (standard
error) represents differences among donors. The number of donors examined is
defined by n.
a Percentage of chemokine production in cells infected with D116N versus
Wt (after subtracting uninfected cell background): CXCL8, 46%; CXCL9,
14%; CXCL10, 33%.
307J. Kelly et al. / Virology 372 (2008) 300–312et al., 1995; Wiskerchen and Muesing, 1995). We also found
higher levels of 2-LTR circles in D116N-infected macrophages
(Fig. 2C). Although the 2-LTR circle could be a template, we
cannot exclude the possibility that other DNA forms such as the
1-LTR circle or the linear viral DNAmay function as a template.
Both DNA forms, along with the 2-LTR circle, persisted with
viral transcription in D116N-infected macrophages. Aside from
these unintegrated viral DNA, virion particles prepared by
transfection carry some plasmid DNA on the surface that could
be introduced into the cell. The plasmid DNA can be removed
by treatment with Benzonase to a level reportedly undetectable
by PCR (Sastry et al., 2004) or three log[10] lower as de-Fig. 5. Wild-type and integrase-negative HIV induction of CXCL10 in macrophages. M
level of either wild-type or the integrase mutant, D116N, and cultured for 4 days e
collected at 4 days post-infection and assayed by ELISA for CXCL10 secretion. Each
represent mean±standard error.monstrated in this report (Fig. 3F). We observed no decrease in
viral transcriptional activity following Benzonase treatment of
the D116N virions (Fig. 3G), excluding any role of contaminat-
ing plasmid DNA in mediating transcription. It is likely that
even the carryover plasmid DNA can enter cells through non-
specific attachment to virion particles, these molecules may not
enter the nucleus for transcription.
The production of chemokines and inflammatory cytokines
by macrophages and microglia, following HIV infection, is
believed to result in both enhanced infection of T cells (Canque
et al., 1996; Swingler et al., 1999; Tedla et al., 1996) as well as
HIV-mediated brain diseases, such as the AIDS dementia
complex (Hickey and Kimura, 1988; Koenig et al., 1986;
Lassmann et al., 1994; Lassmann et al., 1993). Human
monocytes/macrophages exposed to gp120 or inactivated
HIV have been shown to secret elevated levels of TNF, IL-1,
IL-6, IL-10, MCP-1, MIP-1, or Rantes (Borghi et al., 1995;
Clouse et al., 1991; Fantuzzi et al., 2001; Lee et al., 2005).
Infectious virus have been reported to be necessary for
induction of MIP-1, MCP-1, and M-CSF because AZT or
heat-inactivation of the HIV resulted in diminished production
of these cytokines/chemokines (Canque et al., 1996; Kutza et
al., 2000; Mengozzi et al., 1999; Schmidtmayerova et al.,
1996). The induction of CXCL8 (IL-8) is not as well
characterized, but in one study it was found that CXCL8 was
generated from many p24-negative cells in an HIV-infected
population (Glienke et al., 1994), implying that the inducing
factor could be a viral (or cellular) product secreted into the
media. This is consistent with our finding that the addition of
non-replicating D116N HIV or wild-type HIV plus AZT (also
non-replicating) induced similar levels of CXCL8, with both
populations generating lower CXCL8 levels than a macrophage
population supporting spreading HIV (Table 2).onocyte-derived macrophages from healthy donors were infected with an equal
ither in the presence or absence of AZT. Supernatants from cell cultures were
donor cell population underwent three independent infections (n=3) and the data
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be different. Work by Foley et al. (2005) has demonstrated that
the induction of CXCL10 by HIV was eliminated by AZT and
could be mediated by VSV-pseudotyped HIV. These findings
suggest that post-reverse transcription processes are responsible,
and Foley et al. (2005) excluded an interferon-based induction.
Our findings concerning CXCL10 are in agreement with these
findings, and in addition it is noted here that integration is not
essential for induction of this chemokine. A mechanism for HIV
induction of CXCL10 is under investigation.
The induction of CXCL10 by HIV results in a process by
which macrophage activity could affect the in vivo spread of R5
HIV. It was reported that R5 HIV-infected macrophages could
recruit resting CD4 T cells, through secretion of soluble ICAM
and CD23, and then enhance T cell infection with X4 HIV
(Swingler et al., 2003, 1999). CXCL10 largely recruits active
CCR5+ CD4 Tcells (Foley et al., 2005), which could be directly
infected by the R5 HIV-1 released by infected macrophages.
Active T cells are highly susceptible to the R5 virus (Brenchley
et al., 2004; Mattapallil et al., 2005).
A definitive role for unintegrated DNA in the pathogenesis of
HIV infection is unresolved. In other retroviruses, unintegrated
DNA has been implicated in viral pathogenesis. Keshet and
Temin (1979) were the first to suggest a correlation between cell
killing and accumulation of unintegrated DNA in spleen
necrosis virus infection. A similar association has been seen
in avian leukosis virus-induced osteoporosis, feline leukemia
virus-induced feline AIDS, and equine infectious anemia virus
infection of horses (Mullins et al., 1986; Rice et al., 1989;Weller
et al., 1980). In HIV infection of T cells, accumulation of un-
integrated viral DNAwas reported to correlate with the extent of
syncytia formation (Pauza et al., 1990), but not the occurrence of
single-cell killing (Bergeron and Sodroski, 1992). However, it is
not clear whether the mere presence of unintegrated DNA may
trigger certain cellular processes, or products from the DNAmay
aid viral pathogenesis to some extent.
In addition to induction of inflammatory proteins, pathogenic
effects from viral early products such as Nef exist. Nef-
transduced macrophages, when grafted into the rat hippocam-
pus, inducedmonocyte/macrophage recruitment, TNF-α expres-
sion, and astrogliosis (Mordelet et al., 2004). Nef was also found
to regulate the release of superoxide anion from Nef-transduced
human macrophages (Olivetta et al., 2005; van Marle et al.,
2004). Even very low levels of Nef (barely detectable) expressed
in oligodendrocytes were sufficient to mediate vacuolar myelo-
pathy and elicit disease (Radja et al., 2003). The production of
proinflammatory cytokines has been associated with multiple
viral factors such as gp120, Nef and Tat (Koka et al., 1995;
Merrill et al., 1992). We would assume that stimulation of
proinflammatory cytokines by D116N could be a combined
effect of multiple viral factors. Nevertheless, our finding rein-
forced the notion that non-replicative HIVwith limited activity is
still capable of inducing neuronal damage (Pang et al., 1990).
Unintegrated HIV DNA lacks a functional origin of
replication normally present in DNA viruses such as SV40.
Introduction of such an origin leads to DNA amplification and
productive viral replication (Lu et al., 2004). This observationhighlights the full transcriptional potential of unintegrated DNA
and is consistent with a notion that unintegrated circular DNA
is highly stable. These DNA forms decrease in concentration
only as a function of dilution resulting from cell division (Butler
et al., 2002; Pierson et al., 2002). Thus, it is not surprising that in
non-dividing cells, when the cell cycle is arrested, unintegrated
viral DNA can persist (Gillim-Ross et al., 2005a; Saenz et al.,
2004). The ability of unintegrated viral DNA to persist and to
transcribe has stimulated a recent interest in using unintegrating
lentiviral vector to transduce non-dividing cells, such as ocu-
lar or neuronal cells, for gene therapy (Philippe et al., 2006;
Saenz et al., 2004; Yanez-Munoz et al., 2006). These vectors
have demonstrated a surprising efficiency in mediating high
level, stable expression from internally promoted transgenes in
non-dividing cells (Philippe et al., 2006; Saenz et al., 2004;
Yanez-Munoz et al., 2006). Currently, we are also examining
an unintegrating Rev-dependent lentiviral vector (Wu et al.,
2007b) for targeting HIV-1-infected macrophages (unpublished
data). Such vectors would be advantageous for minimizing
integration-mediated mutagenesis. Additionally, the capacity of
unintegrated HIV DNA to persist and express viral genes in
macrophages, a professional antigen-presenting cell, could be
exploited in the development of unintegrating lentiviral vectors
for the delivery of vaccine or therapeutic genes (Lu et al., 2003;
Smith, 2002).
Materials and methods
Viruses and cells
Viral stocks of the HIV-1AD8 and the integrase mutant
HIV-1AD8/D116N (kindly provided by Dr. Malcolm A. Martin)
(Englund et al., 1995) were prepared by transfection of HEK293
T cells as previously described (Wu and Marsh, 2001). To
remove plasmid DNA contamination, we treated viral stock with
Benzonase (Novagen, Madison, WI) (50 to 100 U/ml) at 37 °C
for 15 to 30 min. To measure the extent of plasmid DNA de-
gradation, we purified DNA from treated viruses and then
amplified it with real-time PCR (see below) for measuring full-
length viral DNA.Viral titer wasmeasured by TCID50 assay with
a cloned CEM indicator line with R5 susceptibility (Rev-CEM)
(Wu et al., 2007a,b). Macrophages were differentiated from
human monocytes from the peripheral blood of HIV-1-negative
donors. All protocols involving human subjects were reviewed
and approved by the George Mason University IRB. Briefly, two
million peripheral blood mononuclear cells were plated into each
well of six plates in serum-free RPMI medium for 1 h. Adherent
cells were cultured in RPMI plus 10% heat-inactivated fetal
bovine serum (FBS) with 10 ng/ml macrophage colony
stimulating factor (M-CSF) (R&D System, Minneapolis, MN)
for 2 weeks with medium change for every 2 days. Macrophages
were infected with wild-type virus at a multiplicity of infection
(m. o. i) 0.2. The integrase mutant was used for infection with an
equivalent level of p24 as the wild type. Infection was carried out
at 37 °C for 4 h. Infected cells were washed three times and
continuously cultured in RPMI plus 10% FBS without M-CSF.
Fresh medium was added every 2 days. Viral replication was
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of viral p24 as recommended by the manufacturer (Beckman
Coulter, Miami, FL).
Generation of the D116N Nef deletion mutant,
HIV-1AD8/D116N/Δnef
Nef deletion was first introduced into HIV-1(KFS) (Kindly
provided by Dr. Eric Freed) by inserting a Nef-STOP-Linker
(TGATTGATGACGGCCGTAGTAGTGA) into the unique BlpI
site. The Nef deletion mutant of HIV-1AD8/D116N was then gene-
rated by replacing the XhoI–BamHI fragment of HIV-1AD8/D116N
with the XhoI–BamHI fragment of HIV-1(KFS)Δnef. The Nef
deletion was confirmed by DNA sequencing.
DNA and RNA detection
Total cellular DNAandRNAwere purified using SV total RNA
isolation kit as recommended by the manufacturer (Promega,
Madision, WI). Purified RNA was further treated with DNase I
(DNA-free kit, Ambion Inc., Austin, TX) as recommended by the
manufacturer. Quantitative real-time PCR analyses of viral DNA
and 2-LTR circles were carried out by using ABI Prism 7700
sequence detection system as described previously (Wu and
Marsh, 2003), using the forward primer, 5′LTR-U5: 5′-AGATC-
CCTCAGACCCTTTTAGTCA-3′; the reverse primer, 3′ gag: 5′-
TTCGCTTTCAAGTCCCTGTTC-3′; the probe, FAM-U5/gag:
5 ′-(FAM)-TGTGGAAAATCTCTAGCAGTGGCGCC-
(TAMRA)-3′. DNA standard used for both late DNA and 2-LTR
circle quantification was constructed by using a plasmid contain-
ing a complete 2-LTR region (pLTR-2C, cloned by amplification
of infected cells with 5′-TGGGTTTTCCAGTCACACCTCAG-
3′ and 5′-GATTAACTGCGAATCGTTCTAGC-3′). Measure-
ment was run in triplicate ranging from 1 to 106 copies of pLTR-
2C mixed with DNA from uninfected cells. For the detection of
viral late reverse transcription products by PCR, forward primer:
5′GGTTAGACCAGATCTGAGCCTG 3′ and reverse primer: 5′
TTAATACCGACGCTCTCGCACC 3′ were used. PCR was
carried out in 1× Ambion PCR buffer, 125 μM dNTP, 50 pmol
each primer, 1 U SuperTaq Plus (Ambion Inc., Austin, TX) with
30 cycles at 94 °C for 20 s, 68 °C for 40 s. For detection of circular
viral DNA forms, both the 1-LTR and the 2-LTR circle, primer
LTR-nef2 (5′ TGGGTTTTCCAGTCACACCTCAG 3′) and
LTR-gag (5′ GATTAACTGCGAATCGTTCTAGC 3′) were
used as previously described (Wu and Marsh, 2003). Viral DNA
integration was measured by Alu-PCR as previously described
(Wu and Marsh, 2001). Briefly, nuclear DNA was purified and
subjected to amplification byAlu-LTR PCR, using the Alu primer
(5′ TCCCAGCTACTGGGGAGGCTGAGG3′) and HIV-1-LTR
primer L1 (5′ AGGCAAGCTTTATTGAGGCTTAAGC3′). Fol-
lowing Alu-LTR PCR, a second round of PCR was carried out
using an aliquot equivalent to 1/500 of the PCR products, using
LTR specific primer pairs, L2 (5′CTGTGGATCTACCACACA-
CAAGGCTAC3′) and L3 (5′GCTGCTTATATGTAGCATCT-
GAGGGC3′). Construction of the 1-LTR circle competitor was
achieved byPCRamplification and cloning ofDNA from infected
cells with primer LTR-nef2 and LTR-gag. The resulting plasmidwas digested with AfIII, then treated with Klenow fragment of
DNA polymerase I and self-ligated to generate a new PacI site,
which was used to distinguish the competitor from the 1-LTR
circle.
Quantitative RT-PCR analysis of viral transcripts was carried
out as previously described (Wu and Marsh, 2001, 2003). Briefly,
reverse transcription was accomplished with random decamers
as the first-strand primers. Following cDNA synthesis, PCR
was carried out using primer F2 (5′TAATCGGCCGAACAGGG-
ACTTGAAAGCGAAAG3′) and B4 (5′CCATCGATTGCG-
TCCCAGAAGTTCCACAATCC3′) to amplify viral transcripts,
specifically, doubly spliced transcripts such as nef, tat, and rev.
For relative quantification of RT-PCR, cellular β-actin transcripts
were co-amplified usingQuantumRNAβ-actin Internal Standards
(Ambion Inc., Austin, TX), with a ratio of 1/9 for actin primer/
competitor. To analyze singly spliced viral transcripts such as the
env transcript, we used primer F2 and B3 (5′CCCATCTCCA-
CAAGTGCTGATACTTC3′), whereas for the vif transcript, F2
and B2 (5′CTAGGTCAGGGTCTACTTGTGTGC3′) were used.
For analysis of full-length viral transcripts, mRNA was treated
with DNase I (DNA-free kit, Ambion, Inc., Austin, TX), then
subjected to RT-PCR amplification using primer pair F2 and B1
(5′ TCTGAAGGGATGGTTGTAGCTGTCC3′).
Immunodetection of viral proteins
Viral proteins were detected by resolving proteins on 4–20%
SDS–polyacrylamide gel and electroblotting onto 0.2 μm nit-
rocellulose membrane. A 1:1000 dilution of a human anti-HIV
antiserum (obtained through the NIH AIDS Research and
Reference Program) or a monoclonal antibody against gag (p24)
(Wehrly and Chesebro, 1997) (obtained through the NIH AIDS
Research and Reference Program) was incubated with the
membrane, followed by a secondary goat antihuman antiserum
(1:2000 dilution) or goat antimouse antiserum conjugated with
peroxidase. The Nef protein was detected by using 1:1000
dilution of a sheep anti-Nef antiserum as previously described
(Wu and Marsh, 2001), as well as a rabbit Nef antiserum
(Shugars et al., 1993) (1:4000 dilution) provided by the NIH
AIDS Research and Reference Reagent Program.
Detection of the immunoreactive product by chemilumines-
cence was described previously (Wu and Marsh, 2001). The
light signal was captured on a cooled CCD camera using chemi-
luminescent SuperSignalWest Dura substrate (Pierce, Rockford,
IL). Staining of p24 to identify HIV-infected macrophages was
accomplished as previously described (Wu et al., 2007b).
Chemokine assays
Macrophages were cultured in six well plates as described
above and infected with equivalent p24 levels of either HIV-1AD8
(Wt) or the integrase mutant, HIV-1AD8/D116N (D116N), in the
presence or absence of 50 μM 3′azido-3′deoxythymidine (AZT)
(Calbiochem, San Diego, CA). Following 4 days of culture,
supernatants were assayed by Cytometric Bead Array (BD Bio-
sciences, San Jose, CA) or byELISA (BioSource, Camarillo, CA)
following the manufacturers' recommendations. We made use of
310 J. Kelly et al. / Virology 372 (2008) 300–312the CBA inflammatory cytokine and CBA chemokine kits (BD
Biosciences, San Jose, CA) to survey chemokines CXCL8 (IL-8),
CCL5 (RANTES), CXCL9 (MIG), CCL2 (MCP-1), and
CXCL10 (IP-10) and cytokines TNF, IL-1β, IL-12p70, and IL-
6. In addition, we measured chemokine induction in triplicate by
ELISA from multiple infections of cells from additional donors.
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